Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3522497016 | Product containing amphotericin B liposome (medicinal product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3522498014 | Product containing amphotericin B liposome | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3694954012 | Amphotericin B liposome product | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3637321000005112 | amphotericin B-liposom | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Danish module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| amphotericin B-liposom | Is a | amphotericin til parenteral anvendelse | false | Inferred relationship | Some | ||
| amphotericin B-liposom | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Amphotericin B liposome (substance) | false | Inferred relationship | Some | ||
| amphotericin B-liposom | Has manufactured dose form | injektionsvæske | false | Inferred relationship | Some | ||
| amphotericin B-liposom | Is a | Amphotericin-containing product | false | Inferred relationship | Some | ||
| amphotericin B-liposom | Is a | Product containing amphotericin B (medicinal product) | false | Inferred relationship | Some | ||
| amphotericin B-liposom | Is a | Product containing phospholipid (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Amphotericin (lipid formulation) 50mg powder for infusion solution vial | Is a | False | amphotericin B-liposom | Inferred relationship | Some | |
| Amphotericin (lipid formulation) 100mg powder for infusion solution vial | Is a | False | amphotericin B-liposom | Inferred relationship | Some | |
| amphotericin 5 mg/ml, lipidformulering, suspension til injektionsvæske, hætteglas a 20 ml | Is a | False | amphotericin B-liposom | Inferred relationship | Some | |
| amphotericin 5 mg/ml, lipidformulering, suspension til injektionsvæske, hætteglas a 10 ml | Is a | False | amphotericin B-liposom | Inferred relationship | Some | |
| Product containing amphotericin B liposome in parenteral dosage form | Is a | False | amphotericin B-liposom | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
FHIR